AIM
RMD icon

AXA Investment Managers’s ResMed RMD Stock Holding History

AXA Investment Managers’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$23.9M Buy
+87,327
New +$23.9M 0.06% 259

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

AXA Investment Managers's RMD Position: Q3 2025 in Review

AXA Investment Managers opened a new position in ResMed (RMD) in Q3 2025: 87,327 shares worth $23.9M. The stake represents 0.06% of the portfolio and ranks #259 among its holdings.

949 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • AXA Investment Managers held 87,327 shares of ResMed worth $23.9M as of Q3 2025.
  • ResMed was a new AXA Investment Managers position in Q3 2025.
  • ResMed made up 0.06% of AXA Investment Managers's portfolio in Q3 2025, its #259 holding.
  • 949 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.